Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin
Clinical trial NCT02150824 · COMPLETED
Trial details
- NCT number
- NCT02150824
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.